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transferred and not transferred ? This would
be of great value to many medical and geriatric
services who do not have the facilities of a
stroke unit and who regularly indulge in
transferring stroke patients, albeit at times it
seems in a wholly random fashion.
COLIN POWELL
University Department of Medicine(Geriatric Medicine),
Royal Liverpool Hospital,
Liverpool L7 8XP
***We sent this letter to Dr W M Garraway
and his colleagues, whose reply is printed
below.-ED, BMJ.
SIR,-The limitations inherent in conducting
controlled trials of methods of providing health
services, which we refer to in our paper, mean
that we have no information on the criteria
which were used to transfer a selected group of
patients from medical units during the acute
phase of rehabilitation. But we have been
able to examine the results of standard
clinical tests which were designed to predict
outcome following acute stroke, and which
will form the subject of a future publication.
No difference was found in the pattern of
neurological impairment present in the
transferred group compared with those
patients remaining in medical units through-
out. Therefore it may not be surprising that
there was no difference in outcome between
the two groups. Transferring stroke patients
from medical units for further rehabilitation
appears to be a common practice in Britain,
and on the basis of our results these transfers
should be arranged earlier rather than later if
the full benefits of intensive therapy are to be
realised. But, as Dr Powell correctly infers,
conclusive evidence to support this statement
can come only from further randomised con-
trolled trials.
W M GARRAWAY
A J AKHTAR
R J PRESCOTT
L HOCKEY
University Department of Community Medicine,
Usher Institute,
Edinburgh EH9 lDW
Preventing infection in laboratories
SIR,-As we were not consulted on the draft-
ing of the original report perhaps you will
permit us to make several observations on the
article by Sir James Howie and Mr C H
Collins (19 April, p 1071) entitled "The
Howie Code for preventing infection in
clinical laboratories: comments on some
general criticisms and specific complaints."
It is important to realise that the code
relates to clinical laboratories, a point which
is often not appreciated by authorities re-
sponsible for ensuring safety standards in
non-clinical laboratories. While this does not
imply that the code is irrelevant to non-
clinical laboratories, it does mean that its
interpretation in these non-clinical situations
needs careful consideration and possible
modification to meet local requirements.
In particular, we have in mind the use of
Salmonella typhi in the Rideal Walker test for
disinfectants. While we would not disagree
with the general comments regarding the
dangers of Salmonella typhi as isolated in a
clinical situation we do believe that the
Salmonella strain NCTC 786 as used in the
Rideal Walker test presents a different picture.
The strain is a virulence-negative variant and
while this is not positive proof of the non-
virulence of the organism it does differentiate
it from the normal virulent strains. The strain
has been in use in members' laboratories from
as early as 1904 with well over 450 000 Rideal-
Walker tests conducted during this time,
involving more than 200 laboratory personnel.
There is no recorded case of infection resulting
from the use of this strain during this period.
These facts speak for themselves and need to
be taken into account in reacting to the use of
Salmonella typhi NCTC 786 in the Rideal-
Walker test.
All too often the applicability of Salmonella
typhi NCTC 786 to the testing of modern
disinfectants clouds the issue of the safety
aspect. Manufacturers of disinfectants sell
products on an international basis and the
Rideal-Walker test forms an integral part of
this operation. Naturally, the imposition of
excessive restrictions will place UK companies
in an unfavourable competitive position.
In seeking to clarify the situation with
regard to Salmonella typhi NCTC 786 we
support those who oppose the unnecessary use
of the Rideal-Walker technique using Sal-
monella typhi-for instance, for teaching pur-
poses or evaluating disinfectants for hospital
use, where because of the readily availability
of Salmonella cultures alternatives to strain
NCTC 786 may be inadvertently used.
While we agree with the Howie Code's
recommendation that the use of exhaust
protective cabinets (class 1) is necessary for
most category B pathogens, which cause air-
borne infections, we do not agree that it is
appropriate for organisms causing infection by
the alimentary route such as Salmonella typhi.
To cover this case the association had drawn
up its own code of practice for the handling of
Salmonella typhi NCTC 786 in members'
laboratories.
R A COWEN
Chairman, Disinfectant Testing Committee,
British Association for Chemical Specialities,
London SE1 7TU
Why has Swann failed?
SIR,-In your leading article (17 May, p 1195)
you state that legislation enacted as a con-
sequence of the Swann Report has failed to
prevent the emergence of multiple drug
resistance in Salmonella typhimurium in
bovines in Britain despite the fact that it was
precisely intended to do so. The legislation
was not designed to do this. Its purpose was
to stop the feeding of pigs and table chickens
continuously on diets containing antibiotics
that are commonly used in human and
veterinary medicine, because the practice
had given rise to enormous populations of
antibiotic-resistant bacteria in these animals.
The feeding of such diets to bovines in
Britain had never been permitted.
The Swann legislation, in essence, has now
been adopted by many other countries and I
think Britain can take some pleasure in having
initiated it.
H WILLIAMS SMITH
Houghton Poultry Research Station,
Huntingdon, Cambs PE17 2DA
SIR,-In the excellent leading article "Why
has Swann failed" (17 May, p 1195) I was
surprised that attention was not directed also
to the current agricultural practice of spread-
ing raw fluid slurry on the fields. This practice
could be a possible source for dissemination
of these organisms.
If the fluid comes from stock some of which
is infected with or is a carrier of salmonella
it may reasonably be supposed that when the
field so treated is next grazed the grazing stock
are at risk of infection. It must also place
anybody who may have contact either with the
fluid or with the surface of the field at some
risk of infection. This is less likely to occur
if all the manure is allowed to rot down fully
to compost in a dung heap, for the simple
reason that the heat of a well-made heap will
inhibit if not destroy bacteria. The broad-
casting of fluid slurry in this way is also
socially unacceptable to those unfortunate
enough to live to leeward of the fields so
treated.
The epidemiology, both animal and human,
described in your article suggests that this
practice requires careful scientific study.
A IAN L MAITLAND
St Andrews, Fife
Possible cancer hazard associated with
5-methoxypsoralen in suntan preparation
SIR,-With regard to the current discussion
(3 November, p 1144; 1 March, p 648; 29
March, p 940) on the safety of cosmetics
containing 5-methoxypsoralen (bergapten) I
would like to add a number of points.
(1) Although the current controversy
concerns the suntanning aids containing
bergamot oil, they are not the only cosmetics
involved. Of a total of 108 perfumes investi-
gated, 57 40 contained bergapten in con-
centrations ranging from 0 00004 to 0 0108%.1
Perfumes are therefore likely to produce
phototoxicity unless the psoralens are removed
or the content of 5-methoxypsoralen reduced
to 0.001%.2 Subjects known to be sensitive to
small concentrations of 5-methoxypsoralen
and patients suffering from poikiloderma of
civatte should therefore be warned about all
these preparations.'
(2) The suntanning aids of current concern
contain up to 0 003', (30 ppm) (Chefaro
Proprietaries Ltd, personal communication).
The amount of 5-methoxypsoralen necessary
for the achievement of an enhanced tan has,
however, been reported to exceed 1%.3
(3) Not only is there a possible risk ofhuman
carcinogenicity associated with the use of
methoxypsoralens in combination with ultra-
violet A light, but also there may be as yet
unknown effects on the microbial ecology of
human skin. Methoxypsoralens are known to
induce mutations in various bacteria and
fungi.4 Any genetic changes in skin organisms
may be clinically important with regard, for
example, to acquisition and transfer of
antibiotic resistance.5
(4) Many substances are photosensitisers.
They include several fluorescent dyes (ery-
throsin B), some metabolites (for example,
bilirubin and porphyrins, and drugs like
phenothiazines, tetracyclines, sulphonamides,
thiazides, nalidixic acid, frusemide, quinine,
and anthracene).6 The topical application
therefore of preparations containing another
phototoxic compound, 5-methoxypsoralen,
could lead to an increased photosensitivity in
individuals already sensitised to solar radiation.
(5) All tanning aids contain sunscreens,
which are substances designed to prevent
